Leonard M Tannenbaum

Director Tannenbaum buys 90,600 shares of AFCG at $2.84; prior 5 trades at ticker were 100% well-timed at 90-day mark.

Leonard M Tannenbaum purchased 90,600 shares at $2.84 on 2026-05-14, bringing his holdings to 6,516,775 shares (a +1.4% increase). His prior 5 open-market purchases at Advanced Flower Capital Inc. were all well-timed at the 90-day measurement, with returns ranging from +20.6% to +28.6%, establishing a consistent pattern of favorable timing at this specific ticker. The current purchase occurs at -42.2% from the 52-week high of $5.87, and the stock has risen +47.4% over the past 90 days and +21.9% over the past 30 days. The company reported net income of $11,427,347.00 in the latest quarter against a revenue base of $6,530,948.00, though it was unprofitable over its most recent full fiscal year and has experienced annual revenue decline of -46.2%. The director's accumulation pattern and demonstrated timing track record at this ticker merit investor attention.

Director Tannenbaum purchases 410,677 shares of TCGSX for $4.0M; holdings rise 82.8% to 906,543 shares

TANNENBAUM LEONARD M, a Director, executed a $4,000,000.00 purchase of 410,677 shares at $9.74 on 2026-03-30, increasing his position from 495,865 shares to 906,543 shares—an 82.8% increase in holdings. This represents his fifth consecutive buy at TCGSX over a six-week span (January 9 through March 30, 2026), with no intervening sales. The purchase follows an established pattern: his cross-ticker track record shows 20 prior open-market buys, indicating a consistent propensity to deploy capital in equities. While prior timing outcomes at this ticker remain unmeasurable (all five same-ticker trades are too recent for 90-day assessment), the rapid sequence of accumulation and substantial dollar commitment signal sustained engagement with the fund at current price levels. Investors should monitor whether this multi-week buying pattern reflects opportunistic deployment or a systematic accumulation strategy.

Director TANNENBAUM LEONARD M bought 29,040 shares at $2.76 on 2026-03-31; AFCG stock -56.0% from 52-week high amid -46.2% annual revenue decline.

Director TANNENBAUM LEONARD M purchased 29,040 shares at $2.76 on 2026-03-31, adding to 6,397,135 prior holdings (+0.5% increase). This buy occurs in the context of significant headwinds: AFCG stock is -56.0% from its 52-week high of $6.29, the company reported -46.2% annual revenue decline, and net income was $-12,490,506.00 over the latest fiscal year, indicating sustained unprofitability. The transaction is part of a cluster of five buys within an 11-day span (2026-03-20 through 2026-03-31), suggesting continued accumulation during a period of depressed valuation and operational distress. However, outcomes on these recent purchases are not yet measurable given the near-term filing date.

AFCG Director Tannenbaum buys 24,029 shares at $2.60 across two days; stock down 58.0% from 52-week high amid -46.2% revenue decline.

Leonard M Tannenbaum, a Director at Advanced Flower Capital Inc., executed 2 purchases totaling 24,029 shares for $62,475.40 on 2026-03-26 and 2026-03-27, increasing his holdings to 6,397,135 shares. The buys occurred while the stock trades 58.0% below its 52-week high of $6.29 and the company faces severe operational stress: annual revenue declined 46.2% year-over-year, net income was -$12,490,506.00 for the latest full fiscal year, and most recent quarterly revenue stands at only $6,530,948.00. His prior 5 trades at AFCG over the preceding week (2026-03-18 through 2026-03-24) were all purchases as well, reflecting sustained accumulation despite deteriorating fundamentals. Across his broader cross-ticker open-market history, his 20 prior buys averaged a 30-day return of -1.6%, suggesting a pattern of entry timing that has not translated to short-term gains.

Director TANNENBAUM LEONARD M purchases 174,517 shares over 3 days at blended $2.56; stock now -59.0% from 52-week high, company unprofitable (-$12.5M net income).

TANNENBAUM LEONARD M executed 3 separate purchases totaling 174,517 shares for $447,389.55 between 2026-03-20 and 2026-03-24, at an average price of $2.56, raising his holdings by 2.8% to 6,373,106 shares. The current share price of $2.62 sits -59.0% below the 52-week high of $6.39, reflecting significant depreciation. Fundamentals are concerning: the company reported a net loss of $-12,490,506.00 in its most recent full fiscal year, with annual revenue declining 46.2% year-over-year against a market cap of only $61,645,571.28. Across his cross-ticker track record, TANNENBAUM's prior open-market purchases show a 0.00% win rate at 90 days with an average return of -11.9%, indicating a consistent pattern of unfavorable entry timing. The recent rapid succession of purchases at AFCG (5 trades within days) occurs in a deeply challenged operational environment with persistent losses and severe stock price weakness.

Director Tannenbaum purchased 151,200 shares at $2.59 in two transactions (2 purchases totaling 151.2K shares for $391.6K)

Leonard M. Tannenbaum, Director at Advanced Flower Capital, made 2 separate open-market purchases totaling 151,200 shares for $391,608.00 on March 18–19, 2026, at a blended average of $2.59 per share. His post-transaction holdings of 6,198,589 shares represent a +2.5% increase from prior holdings. The current price of $2.74 reflects a +5.8% gain from his purchase price, though the stock trades 58.6% below its 52-week high of $6.62. Tannenbaum's cross-ticker track record shows 20 prior buys with a 0.00% 90-day win rate and an average 90-day return of -16.0%, raising questions about execution timing; at AFCG specifically, he has made 5 consecutive buy transactions since March 9 (all with unmeasurable 90-day outcomes to date). The company's fundamentals are materially challenged: net income was negative ($-12,490,506.00 for the latest quarter), annual revenue has contracted 46.2% year-over-year, and the company remains unprofitable. The accumulation pattern combined with deteriorating fundamentals warrants investor scrutiny of management's capital allocation rationale.

Director Leonard Tannenbaum purchased 51,808 shares in 3 trades (avg $2.59) on AFCG amid stock down 69.4% from 52-week high and -46.2% revenue decline

Leonard Tannenbaum, a Director at Advanced Flower Capital Inc., executed 3 separate purchases totaling 51,808 shares for $134,332.90 between 2026-03-12 and 2026-03-16, increasing his holdings to 6,047,389 shares. The purchases occurred as the stock trades at $2.60, down 69.4% from its 52-week high of $8.49, while the company faces severe fundamental headwinds: full-year net income was $-12,490,506.00 and annual revenue declined 46.2%. This buying activity follows a cluster of four additional open-market purchases at this same ticker within 6 days prior (2026-03-05 through 2026-03-10), all at similar price points around $2.59–$2.60. Historically, Tannenbaum's cross-ticker buy track record shows an average 90-day return of -13.4% with a 0.00% win rate across 20 prior buys, and his single prior measurable trade at AFCG (2025-12-11) delivered a -13.8% 90-day return, suggesting a pattern of purchases preceding further declines rather than recoveries.

Director Tannenbaum buys 104,213 shares at $2.54 avg ($264.8K) amid -46.2% revenue decline and $-12.5M net loss

LEONARD M TANNENBAUM (Director) executed 2 separate purchases totaling 104,213 shares for $264,761.02 ($264.8K) at a blended average price of $2.54 on March 9–10, 2026, bringing his holdings to 5,995,581 shares (+1.8% increase). The transaction occurred as AFCG's financial condition has deteriorated: the latest quarter showed revenue of $6,530,948.00 while the company posted a net loss of $-12,490,506.00, and annual revenue growth declined -46.2% year-over-year. At the same ticker, Tannenbaum's prior buys on December 9, 10, and 11, 2025 each produced negative 90-day returns (0.0%, -5.3%, -5.9%), indicating no track record of well-timed purchases at this security. The current price of $2.63 is -69.0% below the 52-week high of $8.49, but this open-market purchase by a director during operational losses and revenue contraction warrants attention to whether market conditions or company fundamentals prompted the accumulation.

Director TANNENBAUM bought 30,270 shares over two days for $73,896.90 at AFCG; stock -69.8% from 52-week high, company unprofitable.

Director Leonard M. Tannenbaum made 2 separate purchases totaling 30,270 shares for $73,896.90 ($2.44 blended average) on March 5–6, 2026, increasing holdings to 5,891,368 shares. The timing arrives amid material pressure: Advanced Flower Capital is trading at $2.57, down 69.8% from its 52-week high of $8.52, while the company reported a -$12,490,506.00 net loss on $6,530,948.00 quarterly revenue, with annual revenue decline of -46.2%. At AFCG specifically, Tannenbaum's prior 5 trades show a 0% win rate at the 90-day mark (0 of 2 prior buys were well-timed), and his broader cross-ticker buy track record averaged -9.8% over 90 days. The purchase occurs as the stock has recovered +18.4% over the past 30 days but remains in a structural downturn, with the company unprofitable over its most recent full fiscal year.

Director Tannenbaum buys 184,804 shares of TCGSX for $1,800,000.00 on 2026-02-09, increasing holdings to 495,865 shares.

Leonard M. Tannenbaum, a Director, purchased 184,804 shares of TCG Strategic Income Fund (TCGSX) at $9.74, bringing his total holdings to 495,865 shares—a 59.4% increase from prior holdings of 311,060 shares. This represents his fifth consecutive buy at this ticker within a 35-day window (2026-01-05 through 2026-02-09), suggesting sustained accumulation rather than a single discretionary decision. However, his cross-ticker track record shows poor timing: 20 prior open-market buys across all tickers averaged -36.6% return over 90 days with a 0% win rate, indicating his past purchases have not materialized into gains. None of his TCGSX prior trades yet have measurable 90-day outcomes, so no pattern of timing success or failure exists at this specific ticker to date.